Dr. Musunuri is Chairman, Chief Executive Officer, and Co-Founder of Ocugen—a fully integrated, patient-centric biotech company focused on vaccines in support of public health and gene and cell therapies targeting unmet medical needs through Courageous Innovation. Dr. Musunuri has 30+ years’ biotech experience, advancing and commercializing a diverse portfolio of products. Prior to co-founding Ocugen in 2013, Dr. Musunuri held leadership roles at numerous companies ranging from “Big Pharma” to novel start-up biotech. After a long tenure at Pfizer, he founded Nuron Biotech, Inc., which he grew to a commercial company in less than three years, serving as President and CEO. Dr. Musunuri spent nearly 15 years at Pfizer, where he gained extensive product launch and lifecycle management experience, playing a key role as Global Operations Team Leader for one of the most successful launches in vaccine history, Prevnar 13®.
Dr. Musunuri obtained his PhD in Pharmaceutical Sciences from the University of Connecticut and an MBA from Duke University’s Fuqua School of Business. He is a recipient of the Distinguished Alumnus Award from the University of Connecticut’s School of Pharmacy and served on the advisory Board of Fuqua’s Center for Entrepreneurship and Innovation at Duke University.